Skip to main content
Stephen Brand, MD, Gastroenterology, Danvers, MA, Encompass Health Rehabilitation Hospital of Western Massachusetts

StephenJamesBrandMD

Gastroenterology Danvers, MA

Physician

Are you Dr. Brand?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 2 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Stephen Brand, MD is a gastroenterologist in Danvers, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Connecticut, and Maine. He is affiliated with Encompass Health Rehabilitation Hospital of Western Massachusetts.

Education & Training

  • University of Western Australia Faculty of Medicine
    University of Western Australia Faculty of MedicineClass of 1975

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2015 - 2024
  • MA State Medical License
    MA State Medical License 1990 - 2024
  • ME State Medical License
    ME State Medical License 2013 - 2024
  • NH State Medical License
    NH State Medical License 2012 - 2024
  • RI State Medical License
    RI State Medical License 2012 - 2024

Publications & Presentations

PubMed

Press Mentions

  • Mycovia Pharmaceuticals Announces Positive Topline Results from Its Third Phase 3 Clinical Trial (ultraVIOLET) of Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis
    Mycovia Pharmaceuticals Announces Positive Topline Results from Its Third Phase 3 Clinical Trial (ultraVIOLET) of Oteseconazole for the Treatment of Recurrent Vulvovaginal CandidiasisJanuary 6th, 2021
  • Mycovia Pharmaceuticals Announces Positive Topline Results from Phase 3 VIOLET Studies of Oteseconazole in Patients with Recurrent Vulvovaginal Candidiasis
    Mycovia Pharmaceuticals Announces Positive Topline Results from Phase 3 VIOLET Studies of Oteseconazole in Patients with Recurrent Vulvovaginal CandidiasisDecember 9th, 2020
  • Mycovia Pharmaceuticals Announces Peer-Reviewed Publication of Positive Study Results of Oteseconazole for the Treatment of Acute Vulvovaginal Candidiasis
    Mycovia Pharmaceuticals Announces Peer-Reviewed Publication of Positive Study Results of Oteseconazole for the Treatment of Acute Vulvovaginal CandidiasisAugust 26th, 2020
  • Join now to see all

Grant Support

  • Gut Peptide Expression In The Endocrine PancreasNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
  • Physiological Regulation Of Gastrin Gene ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1992
  • Gut Pepitde Expression In The Endocrine PancreasNational Institute Of Diabetes And Digestive And Kidney Diseases1990

Hospital Affiliations